In these times of tight budgeting, the U.S. government, foundations and private companies are exploring a new idea: awarding prizes for the development of innovative drugs, vaccines and tests for the world's biggest health problems.
In the view of market fundamentalists, government and nonprofits are conflated into the inefficient enemy and their opposite, the private sector, embodies all that is true and noble. This claptrap is ideological, rigid and disconnected from reality.